MorphoSys has regained rights to MOR202 from Celgene Read the full story
MorphoSys has regained rights to MOR202 from Celgene Read the full story
Promethera Biosciences announced the completion of its Series C fundraising round Read the full story
The Partnering Agreements with Pharmacyclics report provides an in-depth insight into the partnering interests and activities of one of the worlds leading biopharma companies. Read the full story
The Partnering Agreements with Jazz Pharmaceuticals report provides an in-depth insight into the partnering interests and activities of one of the worlds leading biopharma companies. Read the full story
The Partnering Agreements with Salix Pharmaceuticals report provides an in-depth insight into the partnering interests and activities of one of the worlds leading biopharma companies. Read the full story
The Partnering Agreements with Zeltia report provides an in-depth insight into the partnering interests and activities of one of the worlds leading biopharma companies. Read the full story
The Partnering Agreements with Viropharma report provides an in-depth insight into the partnering interests and activites of one of the worlds leading biopharma companies. Read the full story
The Partnering Agreements with Vertex Pharmaceuticals report provides an in-depth insight into the partnering interests and activites of one of the worlds leading biopharma companies. Read the full story
The Partnering Agreements with United Therapeutics report provides an in-depth insight into the partnering interests and activites of one of the worlds leading biopharma companies. Read the full story
The Partnering Agreements with The Medicines Company report provides an in-depth insight into the partnering interests and activites of one of the worlds leading biopharma companies. Read the full story